- Home
- SYTA vs MTNB Comparison
SYTA vs MTNB Comparison
Compare SYTA & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- MTNB
- Stock Information
- Founded
- SYTA 1986
- MTNB 2013
- Country
- SYTA Canada
- MTNB United States
- Employees
- SYTA N/A
- MTNB N/A
- Industry
- SYTA Telecommunications Equipment
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- MTNB Health Care
- Exchange
- SYTA Nasdaq
- MTNB Nasdaq
- Market Cap
- SYTA 3.1M
- MTNB 3.1M
- IPO Year
- SYTA 2020
- MTNB N/A
- Fundamental
- Price
- SYTA $2.08
- MTNB $0.55
- Analyst Decision
- SYTA
- MTNB Hold
- Analyst Count
- SYTA 0
- MTNB 1
- Target Price
- SYTA N/A
- MTNB N/A
- AVG Volume (30 Days)
- SYTA 736.2K
- MTNB 29.8K
- Earning Date
- SYTA 05-15-2025
- MTNB 05-08-2025
- Dividend Yield
- SYTA N/A
- MTNB N/A
- EPS Growth
- SYTA N/A
- MTNB N/A
- EPS
- SYTA N/A
- MTNB N/A
- Revenue
- SYTA $11,629,572.00
- MTNB N/A
- Revenue This Year
- SYTA $75.92
- MTNB N/A
- Revenue Next Year
- SYTA $19.72
- MTNB N/A
- P/E Ratio
- SYTA N/A
- MTNB N/A
- Revenue Growth
- SYTA 41.59
- MTNB N/A
- 52 Week Low
- SYTA $1.82
- MTNB $0.48
- 52 Week High
- SYTA $885.60
- MTNB $13.95
- Technical
- Relative Strength Index (RSI)
- SYTA 40.18
- MTNB 47.48
- Support Level
- SYTA $1.88
- MTNB $0.52
- Resistance Level
- SYTA $2.48
- MTNB $0.58
- Average True Range (ATR)
- SYTA 0.33
- MTNB 0.05
- MACD
- SYTA 0.11
- MTNB 0.00
- Stochastic Oscillator
- SYTA 11.17
- MTNB 36.84
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.